Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Arlene Siefker-Radtke MD

Arlene Odelia Siefker-Radtke MD

Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Dr. Arlene Siefker-Radtke is Associate Professor in the Department of Genitourinary Medical Oncology at the University of Texas MD Anderson Cancer Center and is Clinical Co-Leader of the Bladder SPORE Executive Committee in Houston. Additionally, she serves on the Advisory Board of the PanCanadian Urachal Cancer Study (PUCS) Urachal Tumour DNA Sequencing Project in Ottawa, Canada.

An active researcher, Dr. Siefker-Radtke has published well over 80 journal articles, abstracts, editorials, and book chapters. She was awarded her medical degree from Johns Hopkins University School of Medicine and received her residency training in internal medicine at the New England Medical Center Hospital in Boston. She completed her fellowship in medical oncology at MD Anderson.

Recent Contributions to PracticeUpdate:

  1. An Overview of Targeted FGFR3 Therapy in Bladder Cancer With Dr. Siefker-Radtke: PracticeUpdate’s ESMO Coverage
  2. Current Concepts in Managing Rare Histologies in Bladder Cancer With Dr. Siefker-Radtke: PracticeUpdate’s ESMO Coverage

Most Read This Week

Recently Updated